EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience

Li Yen Ng, Jonathan McGuinness, Terence Prendiville, Orla Franklin, Mark Walsh, Damien Kenny, Lars Nolke, Colin J McMahon

Pediatric Cardiology · 2024-06 · 45 (5) · 1132-1141

DOI: 10.1007/s00246-024-03420-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Cardiology, online erschienen am 13.03.2024. Verfasst von Li Yen Ng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Dublin, 12, Ireland. Hauptthemen laut MEDLINE: Heart Neoplasms, Rhabdomyoma, Ventricular Outflow Obstruction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac rhabdomyomas are the most common benign pediatric heart tumor in infancy, which are commonly associated with tuberous sclerosis complex (TSC). Most rhabdomyomas are asymptomatic and spontaneously regress over time. However, some cases especially in neonates or small infants can present with hemodynamic instability. Surgical resection of the tumor, which has been the gold standard in alleviating obstruction, is not always possible and may be associated with significant morbidity and mortality. Recently, mammalian target of rapamycin inhibitors (mTORi) have been shown to be safe and effective in the treatment of TSC. We present the outcomes of neonates and an infant who received treatment for symptomatic rhabdomyomas at a tertiary cardiology center. Medical records were reviewed to obtain clinical, demographic, and outcome data. Six patients received interventions for symptomatic rhabdomyomas, median age at presentation was 1 day old (range from 1 to 121 days old), and 67% of the patients had a pathogenic mutation in TSC gene. One patient underwent surgical resection of solitary tumor at right ventricular outflow tract (RVOT) successfully. In the four patients with left ventricular outflow tract (LVOT) obstruction, two patients received combined therapy of surgical debulking of LVOT tumor, Stage I palliation procedure, and mTORi and two patients received mTORi therapy. One patient with RVOT obstruction underwent ductal stenting and received synergistic mTORi. Four of the five patients had good response to mTORi demonstrated by the rapid regression of rhabdomyoma size. 83% of patients are still alive at their latest follow-up, at two to eight years of age. One patient died on day 17 post-LVOT tumor resection and Hybrid stage one due to failure of hemostasis, in the background of familial factor VII deficiency. Treatment of symptomatic rhabdomyoma requires individualized treatment strategy based on the underlying pathophysiology, with involvement of multidisciplinary teams. mTORi is effective and safe in inducing rapid regression of rhabdomyomas. A standardized mTORi prescription and monitoring guide will ensure medication safety in neonates and infants with symptomatic cardiac rhabdomyoma. Although the majority of tumors responded to mTORi, some prove to be resistant. Further studies are warranted, ideally involving multiple international centers with a larger number of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart NeoplasmsRhabdomyomaVentricular Outflow ObstructionHumansInfantInfant, NewbornMaleFemaleRetrospective StudiesTreatment OutcomeEchocardiographyTuberous SclerosisCardiac Surgical ProceduresMTOR Inhibitors

Stichwörter der Autor:innen

Cardiac rhabdomyomasMammalian target of rapamycin inhibitorPrimary cardiac tumorTuberous sclerosis complex

Substanzen

MTOR Inhibitors

Autor:innen und Institutionen

  • Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Dublin, 12, Ireland.
  • Department Paediatric Cardiology, Department of Congenital Cardiothoracic Surgery, Children's Health Ireland, Crumlin, Dublin, 12, Ireland.
  • Department of Paediatric Cardiology, Children's Health Ireland at Crumlin, Dublin, 12, Ireland. cmcmahon992004@yahoo.com.
  • UCD School of Medicine, Belfield, Dublin, 4, Ireland. cmcmahon992004@yahoo.com.
  • Maastricht School of Health Professions Education, Maastricht, The Netherlands. cmcmahon992004@yahoo.com.

Zitieren

APA

Ng, L. Y., McGuinness, J., Prendiville, T., Franklin, O., Walsh, M., Kenny, D., Nolke, L., & McMahon, C. J. (2024). Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience. Pediatric Cardiology, 45(5), 1132-1141. https://doi.org/10.1007/s00246-024-03420-0

Vancouver

Ng LY, McGuinness J, Prendiville T, Franklin O, Walsh M, Kenny D, et al. Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience. Pediatric Cardiology. 2024;45(5):1132-1141. doi:10.1007/s00246-024-03420-0

BibTeX
@article{Ng2024,
  author = {Ng, Li Yen and McGuinness, Jonathan and Prendiville, Terence and Franklin, Orla and Walsh, Mark and Kenny, Damien and Nolke, Lars and McMahon, Colin J},
  title = {Cardiac Rhabdomyomas Presenting with Critical Cardiac Obstruction in Neonates and Infants: Treatment Strategies and Outcome, A Single-Center Experience},
  journal = {Pediatric Cardiology},
  year = {2024},
  volume = {45},
  number = {5},
  pages = {1132--1141},
  doi = {10.1007/s00246-024-03420-0}
}
Kostenlos starten →